Literature DB >> 9744549

Effect of promoter and intron 2 polymorphisms on murine lung K-ras gene expression.

S E Jones-Bolin1, E Johansson, W A Palmisano, M W Anderson, J S Wiest, S A Belinsky.   

Abstract

Differences in tumor formation among inbred mouse strains with high (A/J) and low (C3H) susceptibility for lung cancer have been linked to a repetitive element within the second intron of the K-ras gene. The purpose of this investigation was to determine whether differences within the K-ras gene promoter region or the intron 2 polymorphism affect K-ras gene expression in lung tumors and target alveolar type II cells isolated from A/J and C3H mice. Ribonuclease protection assays were performed using RNA isolated from 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced lung tumors from each mouse strain and alveolar type II cells isolated from A/J and C3H mice. An 838 bp fragment of the murine K-ras gene promoter region was amplified by PCR, cloned and sequenced from both mouse strains. Promoter regions from both mouse strains were inserted into a luciferase reporter gene vector, with and without the second intron polymorphism, and transfected into sensitive, intermediate and resistant lung tumor cell lines. No significant differences in K-ras gene promoter activity was found between the two strains using these specific reporter gene constructs. Consistent with these results, levels of K-ras expression did not differ between alveolar type II cells, whole lung or tumors induced by NNK in A/J or C3H mice. Moreover, in lung tumor cell lines derived from mice with differing susceptibility for lung cancer, K-ras expression did not correlate with the growth rate of tumors induced in nude mice from these cell lines. These results indicate that factors involved in modulating the rapid clonal expansion of the mutated K-ras allele from A/J mice are not directly linked to expression of this gene. Other genetic changes or losses in conjunction with hypothesized modifier loci, such as the Par1 locus, must play a significant role in establishing the phenotypic strain differences for lung tumor formation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9744549     DOI: 10.1093/carcin/19.8.1503

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  5 in total

1.  Nicotine does not enhance tumorigenesis in mutant K-ras-driven mouse models of lung cancer.

Authors:  Colleen R Maier; M Christine Hollander; Evthokia A Hobbs; Irem Dogan; R Ilona Linnoila; Phillip A Dennis
Journal:  Cancer Prev Res (Phila)       Date:  2011-10-25

2.  Inhibition of lung tumorigenesis by metformin is associated with decreased plasma IGF-I and diminished receptor tyrosine kinase signaling.

Authors:  Brendan J Quinn; Matthew Dallos; Hiroshi Kitagawa; Ajaikumar B Kunnumakkara; Regan M Memmott; M Christine Hollander; Joell J Gills; Phillip A Dennis
Journal:  Cancer Prev Res (Phila)       Date:  2013-06-14

3.  Gene regulation mediated by microRNAs in response to green tea polyphenol EGCG in mouse lung cancer.

Authors:  Hong Zhou; Jayson X Chen; Chung S Yang; Mary Qu Yang; Youping Deng; Hong Wang
Journal:  BMC Genomics       Date:  2014-12-16       Impact factor: 3.969

4.  Pulsatile MEK Inhibition Improves Anti-tumor Immunity and T Cell Function in Murine Kras Mutant Lung Cancer.

Authors:  Hyejin Choi; Jiehui Deng; Shuai Li; Tarik Silk; Lauren Dong; Elliott J Brea; Sean Houghton; David Redmond; Hong Zhong; Jonathan Boiarsky; Esra A Akbay; Paul D Smith; Taha Merghoub; Kwok-Kin Wong; Jedd D Wolchok
Journal:  Cell Rep       Date:  2019-04-16       Impact factor: 9.423

5.  Mouse pulmonary adenoma susceptibility 1 locus is an expression QTL modulating Kras-4A.

Authors:  Alice Dassano; Francesca Colombo; Gaia Trincucci; Elisa Frullanti; Antonella Galvan; Angela Pettinicchio; Loris De Cecco; Andrea Borrego; Olga Célia Martinez Ibañez; Tommaso A Dragani; Giacomo Manenti
Journal:  PLoS Genet       Date:  2014-04-17       Impact factor: 5.917

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.